Patrick Campbell

A new analysis of two-year data from the FOURIER trial is shedding light on the impact of PCSK9 use for lowering LDL-C.

A new study from investigators in Finland found a single-lead ECG in a necklace could aid in diagnosis of AF.

New research suggests an SBP target of 120 mmHg or less could lower risk of AFib up to 26%.

The Chief Medical Officer of the Sickle Cell Disease Association of America discusses a recently released care provider advisory from the organization.

The latest scientific statement from the AHA addresses cardiovascular considerations before, during, and after pregnancy.

The AAN has released an update to their 2016 practice advisory—changing their stance on PFO closure to reduce risk of second stroke.

New research suggests childhood trauma and dysfunction could increase risk of CVD by up to 68%.

A new review has found less than 50% of the information presented at conferences, including AAO and ARVO, never gets published in peer-reviewed journals.

An analysis of the CITU study is shedding light on the impact of e-cigarette use on arterial stiffness and vascular health.

A new analysis of the FOURIER trial is diving into whether evolocumab use could slow or prevent progression of aortic stenosis.

Results of the study from investigators at CHOP could have real-world impact on treatment algorithms.

A prespecified subanalysis revealed evolocumab use was associated with a significant reduction in risk of MI.

Brief intermittent EEG may not have enough sensitivity for detecting potentially treatable seizures in cardiac arrest patients who required resuscitation.

New research suggests severe sleep apnea was linked to increased blood glucose levels in African-Americans.

New research from investigators in Europe is shedding light on the impact of mental stress on risk of peripheral artery disease

A new review is shedding light on the impact of becoming wealthy on a person's overall health.

Discussing how the ACC has responded to the ongoing outbreak and the potential lasting impact of COVID-19 on the College.

While stay-at-home orders have slowed the spread of COVID-19, Thomas Maddox, MD, and the ACC are concerned it may be having a dangerous secondary impact.

Discussing how COVID-19 impacts the cardiovascular health of infected patients with the Chair of the ACC's Science and Quality Committee.

New research from the RED VELVT trial is shedding further light on the discussion surrounding off-label use of DOACs for left ventricular thrombi.

New research from investigators in Poland suggests losses by a local sports team were associated with a 27% increase in acute coronary syndrome admissions.

While the determination that consumption of coffee is beneficial or harmful depends on the study, new research is diving further into the debate and into how brewing method might play a role in coffee’s impact on cardiovascular disease and mortality.

New research from a hospital in Wuhan has found no difference in hypertension patients whether or not they were taking ACEi/ARBs on admission.

New research from an NIH-funded study suggest 0.004 mg bevacizumab could be an effective treatment for type 1 retinopathy of prematurity.

Analysis of more than 500k Norwegians has found filtered coffee might reduce risk of death and cardiovascular disease, while unfiltered coffee increased risk in older men.

Discussing recent data from GALACTIC-HF with John Teerlink, MD, Executive Committee Chair for both GALACTIC-HF and COSMIC-HF.

New research from Weill Cornell Medicine is revealing more about the impact of social determinants on 90-day mortality following heart failure hospitalization.

New analysis of nationwide mortality statistics from the CDC is shedding light on an alarming trend among women in rural areas across the US.

Despite advances in recent decades in the battle against cardiovascular disease, new research suggests deaths from premature coronary artery disease (CAD) among rural women have been on the rise since 2009.

Discussing the impact of COVID-19 on clinical trials that are ongoing or in development with John Teerlink, MD, Executive Committee Chair of GALACTIC-HF.